Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
104.6 INR | +0.34% | -3.46% | -9.20% |
May. 14 | Zim Laboratories' Consolidated Profit Climbs in Fiscal Q4; Shares Slide 5% | MT |
May. 13 | ZIM Laboratories Limited Reports Earnings Results for the Full Year Ended March 31, 2024 | CI |
Sales 2022 | 3.34B 40.05M | Sales 2023 | 3.99B 47.87M | Capitalization | 3.53B 42.37M |
---|---|---|---|---|---|
Net income 2022 | 146M 1.75M | Net income 2023 | 244M 2.93M | EV / Sales 2022 | 0.93 x |
Net Debt 2022 | 499M 5.99M | Net Debt 2023 | 557M 6.69M | EV / Sales 2023 | 1.02 x |
P/E ratio 2022 |
17.8
x | P/E ratio 2023 |
14.5
x | Employees | 525 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 32.62% |
1 day | +0.34% | ||
1 week | -3.46% | ||
Current month | -13.56% | ||
1 month | -15.59% | ||
3 months | -3.46% | ||
6 months | -10.13% | ||
Current year | -9.20% |
Managers | Title | Age | Since |
---|---|---|---|
Anwar Siraj Daud
CEO | Chief Executive Officer | - | 89-12-31 |
Director of Finance/CFO | - | 19-03-31 | |
Director of Finance/CFO | - | 90-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Anwar Siraj Daud
CEO | Chief Executive Officer | - | 89-12-31 |
Director of Finance/CFO | - | 90-12-31 | |
Prakash Sapkal
COO | Chief Operating Officer | - | 12-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-29 | 104.6 | +0.34% | 1 787 |
24-05-28 | 104.3 | +0.34% | 59,809 |
24-05-27 | 104 | -3.48% | 17,093 |
24-05-24 | 107.7 | -1.91% | 13,049 |
24-05-23 | 109.8 | +1.29% | 7,498 |
Delayed Quote Bombay S.E., May 29, 2024 at 12:37 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-9.20% | 61.09M | |
+16.96% | 42.25B | |
+15.31% | 21.27B | |
+19.33% | 15.23B | |
+18.75% | 14.36B | |
+51.18% | 12.74B | |
-0.05% | 6.79B | |
-12.28% | 6.61B | |
-8.87% | 5.73B | |
+14.28% | 5.66B |
- Stock Market
- Equities
- ZIMLAB Stock